Bismuth nanoparticles against microbial infections.
Foroogh NeamatiMansoor KodoriMohammad Mehdi FeizabadiMohammad AbavisaniMohammad BaraniMansoor KhalediMasoud MoghadaszadehMohammad Karim AzadbakhtMojdeh ZeinaliHadis FathizadehPublished in: Nanomedicine (London, England) (2023)
The destructive effect of infectious diseases on human life and the emergence of antibiotic-resistant strains highlight the importance of developing new and appropriate treatment strategies, one of which is the use of metals as therapeutic agents. Bismuth nanoparticles are an example of prominent metal-containing drugs. The therapeutic effects of bismuth-based drugs in the treatment of wounds have been proven. Various laboratory studies have confirmed the antimicrobial effects of bismuth nanoparticles, including the clinical treatment of ulcers caused by Helicobacter pylori . Therefore, considering the performance of this nanoparticle and its potent effect on infectious agents and its therapeutic dimensions, the present study fully investigated the properties and performance of this metal-based nanoparticle.
Keyphrases
- helicobacter pylori
- infectious diseases
- endothelial cells
- escherichia coli
- staphylococcus aureus
- helicobacter pylori infection
- oxide nanoparticles
- microbial community
- combination therapy
- mass spectrometry
- drug induced
- high resolution
- iron oxide
- human health
- atomic force microscopy
- walled carbon nanotubes
- induced pluripotent stem cells
- health risk assessment